title: Special treatment issues: maintaining and discontinuing psychotropic medications.
authors.affiliation: Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, USA.
authors.forename: T
authors.initials: T
authors.lastname: Suppes
authors.forename: R J
authors.initials: RJ
authors.lastname: Baldessarini
authors.forename: N
authors.initials: N
authors.lastname: Motohashi
authors.forename: L
authors.initials: L
authors.lastname: Tondo
authors.forename: A C
authors.initials: AC
authors.lastname: Viguera
mesh_terms: D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000145:classification; D001714:Bipolar Disorder / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy*; D003866:Depressive Disorder / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000009:adverse effects* / Q000145:classification; D012008:Recurrence; D012307:Risk Factors; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000523:psychology
chemical_list: D000928:Antidepressive Agents; D011619:Psychotropic Drugs